MPARX

Maine Pharmacy Association

DHHS shared guidance documents for e-prescribing and opioid dispensing

DHHS shared guidance documents for e-prescribing and opioid dispensing.  Notably, “A pharmacist is NOT required to verify that a practitioner has a waiver of the requirement to electronically prescribe…” To review the official documents, please click on the links below. Electronic-Prescribing-Clarifications Opioid Dispensing Clarification    

E-Prescribing Grace Period Notice and Chapter 488 User Guide

The deadline for mandatory e-prescribing of opioids was rapidly approaching on July 1st. However, the State sent the following communication announcing a 31 day grace period for enforcement of the penalties for violating the e-prescribing provision.  This is good news and will give prescribers and dispensers a little more time to prepare. DHHS provided material on other provisions in Chapter […]

2017 Scholarship Golf Scramble

Join us for our 2017 Scholarship Golf Scramble ! Where: Val Halla Country Club When: Saturday, August 12, 2017 Shotgun start 1pm Includes 18 holes of golf on a championship course, golf cart, BBQ dinner at Rachel’s on the Green! Cost: Single Golfer: $110.00 Foursome: $400.00 Dinner Only: $35.00 Corporate or personal hole sponsorship: $75 […]

Pharmacists from across Maine convene in Augusta to advocate for profession and patients

Pharmacists and pharmacy students from across the state convened in Augusta on May 30th to advocate for LD 572.   Update: Senate passes LD 572; now on to the House!  LD 572 specifies in statute that the “Practice of Pharmacy” is “the provision of health care services” and that “Pharmacists” are “providers of health care services”. […]

LD6 and LD44 Are Successfully Moving Through the Legislative Process

Good news!!  Two bills, LD 6, an “An Act to Prohibit Insurance Carriers from Retroactively Reducing Payment on Clean Claims Submitted by Pharmacies” and LD 455, “An Act Relating to the Provision of Smoking Cessation Services by Pharmacists” are moving through the legislature process. LD 6, an “An Act to Prohibit Insurance Carriers from Retroactively Reducing Payment on […]

Archive for September, 2013

“The harm imposed by substandard or counterfeit medicine is all too real.  Unscrupulous manufacturers or distributors replace expensive medicines with cheaper, less effective ones – or even worthless maize meal or chalk.”  Watch the video from Notre Dame University and learn more. http://www.youtube.com/watch?v=r0B0z7MqbsM

FAKE.REAL“Fueled by easy internet sales, global supply routes, and minimal punishments, counterfeit prescription drugs have become an exploding industry, with an estimated market worth $75 billion a year worldwide. Long the scourge of developing countries, fake drugs are now popping up in the United States. In 2012, a counterfeit version of the cancer drug Avastin was widely distributed in the U.S., and a fake version of the ADHD drug Adderall, in high demand because of a shortage, arrived in the U.S. through internet pharmacies. In early 2013, the U.S. Food and Drug Administration (FDA) warned doctors that a fake version of another cancer drug, Altuzan, containing no active ingredient, was being distributed in the United States. An estimated 80% of counterfeit drugs come from overseas, and most of them are manufactured in India and China. In this era of globalization, the supply chain for genuine pharmaceuticals has grown longer, and every link offers an opportunity for counterfeiters.” – Barbara Moran

The entire pbs article can be found here:

http://www.pbs.org/wgbh/nova/next/body/uncovering-counterfeit-medicines/


RE: An Act To Facilitate the Personal Importation of Prescription Drugs from International Mail Order Prescription Pharmacies

http://www.mparx.com/wp-content/uploads/2013/08/Maine-126-SP-60-item-4.pdf

OUR KEY CONCERNS

Our primary concerns about the new law are a lack of safety and privacy, unlicensed practice, and it’s illegal.

SAFETY AND PRIVACY:
This new law breaks the safe and secure drug supply system in the US.  FDA inspections have revealed that up to 69% of Rx drugs in mail shipments from foreign countries are unsafe and Canadian parcels accounted for 80% of those prescriptions.  Examples of potentially dangerous products included counterfeit drugs, unapproved drugs, controlled substances, drugs withdrawn from the US market for safety reasons, and improperly packaged drugs.

This year, the FDA shut down 1,677 illegal pharmacy websites that sell potentially dangerous, unapproved prescription medications.  The National Association of Boards of Pharmacy has reviewed over 10,000 online pharmacies and found that 97% are not compliant with practice standards.

Furthermore, international mail order brokers are not required to be HIPAA compliant. They can violate and sell your protected health information without any consequences.

The entire document can be found here:

http://www.mparx.com/wp-content/uploads/2013/09/MPA-Key-Concerns-with-Rx-Drug-Importation-Law1.pdf

Maine Pharmacy Association, Retail Association of Maine, Maine Society of Health System Pharmacists and PhRMA Commence Legal Action Regarding Maine Importation Legislation
Law Attempts to Usurp Federal Regulatory Power and Puts Patients at Risk

Augusta, ME (September 10, 2013) Today, the Maine Pharmacy Association, Retail Association of Maine, Maine Society of Health System Pharmacists, Pharmaceutical Researchers and Manufacturers of America (PhRMA) and several individual Maine pharmacists filed suit in the United States District Court for the District of Maine challenging the legality of a pharmaceutical importation ordinance that was passed by the Maine legislature earlier this year. Due to the recently passed law’s potential to jeopardize the safe and secure prescription medicine distribution system in the United States, the organizations believe that the safety of Maine patients is threatened.

A full copy of our press release can be found here:

http://www.mparx.com/wp-content/uploads/2013/09/Press-Release-September-10-2013.pdf

Maine Department of Professional and Financial Regulation

Office of Professional and Occupational Regulation

Job Announcement – Regulatory Health Compliance Agent